447 related articles for article (PubMed ID: 16421600)
41. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
42. A first-generation packaging cell line for Epstein-Barr virus-derived vectors.
Delecluse HJ; Pich D; Hilsendegen T; Baum C; Hammerschmidt W
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5188-93. PubMed ID: 10220441
[TBL] [Abstract][Full Text] [Related]
43. A packaging system for SV40 vectors without viral coding sequences.
Fang B; Koch P; Bouvet M; Ji L; Roth JA
Anal Biochem; 1997 Dec; 254(1):139-43. PubMed ID: 9398356
[TBL] [Abstract][Full Text] [Related]
44. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
Li C; Samulski RJ
Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
[TBL] [Abstract][Full Text] [Related]
45. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
46. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.
Luo J; Deng ZL; Luo X; Tang N; Song WX; Chen J; Sharff KA; Luu HH; Haydon RC; Kinzler KW; Vogelstein B; He TC
Nat Protoc; 2007; 2(5):1236-47. PubMed ID: 17546019
[TBL] [Abstract][Full Text] [Related]
47. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
Del Vecchio C; Calistri A; Lombardi G; Celegato M; Biasolo MA; Palù G; Parolin C
Gene Ther; 2009 Feb; 16(2):279-90. PubMed ID: 19037240
[TBL] [Abstract][Full Text] [Related]
48. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.
Cockrell AS; Ma H; Fu K; McCown TJ; Kafri T
Mol Ther; 2006 Aug; 14(2):276-84. PubMed ID: 16516556
[TBL] [Abstract][Full Text] [Related]
49. Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration.
Bowers WJ; Howard DF; Federoff HJ
Mol Ther; 2000 Mar; 1(3):294-9. PubMed ID: 10933945
[TBL] [Abstract][Full Text] [Related]
50. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system.
Corbeau P; Kraus G; Wong-Staal F
Gene Ther; 1998 Jan; 5(1):99-104. PubMed ID: 9536270
[TBL] [Abstract][Full Text] [Related]
51. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
[TBL] [Abstract][Full Text] [Related]
52. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
53. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
54. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.
Sun TQ; Livanos E; Vos JM
Gene Ther; 1996 Dec; 3(12):1081-8. PubMed ID: 8986434
[TBL] [Abstract][Full Text] [Related]
55. High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.
Wendtner CM; Kurzeder C; Theiss HD; Kofler DM; Baumert J; Delecluse HJ; Janz A; Hammerschmidt W; Hallek M
Exp Hematol; 2003 Feb; 31(2):99-108. PubMed ID: 12591274
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
57. Properties of Sindbis virus vectors produced with a chimeric split helper system.
Ketola A; Schlesinger S; Wahlfors J
Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906
[TBL] [Abstract][Full Text] [Related]
58. Stable transduction of primary human monocytes by simian lentiviral vector PBj.
Mühlebach MD; Wolfrum N; Schüle S; Tschulena U; Sanzenbacher R; Flory E; Cichutek K; Schweizer M
Mol Ther; 2005 Dec; 12(6):1206-16. PubMed ID: 16150648
[TBL] [Abstract][Full Text] [Related]
59. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
[TBL] [Abstract][Full Text] [Related]
60. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
Zaupa C; Revol-Guyot V; Epstein AL
Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
